Proactiveinvestors USA & Canada ANGLE PLC https://www.proactiveinvestors.com Proactiveinvestors USA & Canada ANGLE PLC RSS feed en Mon, 08 Mar 2021 11:21:38 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) ANGLE says FDA additional information request was expected https://www.proactiveinvestors.com/companies/news/942951/angle-says-fda-additional-information-request-was-expected-942951.html Thu, 04 Mar 2021 07:31:00 -0500 https://www.proactiveinvestors.com/companies/news/942951/angle-says-fda-additional-information-request-was-expected-942951.html Proactive news headlines: MGC Pharmaceuticals, ANGLE, Scirocco Energy, Inspiration Healthcare... https://www.proactiveinvestors.com/companies/news/941689/proactive-news-headlines-mgc-pharmaceuticals-angle-scirocco-energy-inspiration-healthcare-941689.html Thu, 18 Feb 2021 15:30:00 -0500 https://www.proactiveinvestors.com/companies/news/941689/proactive-news-headlines-mgc-pharmaceuticals-angle-scirocco-energy-inspiration-healthcare-941689.html ANGLE says Parsortix system able to harvest difficult-to-detect cancer cells https://www.proactiveinvestors.com/companies/news/941659/angle-says-parsortix-system-able-to-harvest-difficult-to-detect-cancer-cells-941659.html Thu, 18 Feb 2021 07:29:00 -0500 https://www.proactiveinvestors.com/companies/news/941659/angle-says-parsortix-system-able-to-harvest-difficult-to-detect-cancer-cells-941659.html ANGLE liquid biopsy proves its worth assessing lung cancer patients https://www.proactiveinvestors.com/companies/news/940615/angle-liquid-biopsy-proves-its-worth-assessing-lung-cancer-patients-940615.html Mon, 08 Feb 2021 07:48:00 -0500 https://www.proactiveinvestors.com/companies/news/940615/angle-liquid-biopsy-proves-its-worth-assessing-lung-cancer-patients-940615.html ANGLE says five-year study identifies the “key advantages” of the company’s liquid biopsy system https://www.proactiveinvestors.com/companies/news/939825/angle-says-five-year-study-identifies-the-key-advantages-of-the-companys-liquid-biopsy-system-939825.html Fri, 29 Jan 2021 07:50:00 -0500 https://www.proactiveinvestors.com/companies/news/939825/angle-says-five-year-study-identifies-the-key-advantages-of-the-companys-liquid-biopsy-system-939825.html ANGLE present at the Proactive One2One live virtual conference https://www.proactiveinvestors.com/companies/news/939267/angle-present-at-the-proactive-one2one-live-virtual-conference-939267.html Fri, 22 Jan 2021 13:40:00 -0500 https://www.proactiveinvestors.com/companies/news/939267/angle-present-at-the-proactive-one2one-live-virtual-conference-939267.html ANGLE liquid biopsy beats the gold standard when it comes to identifying cells that are indicative of cancer spread https://www.proactiveinvestors.com/companies/news/938952/angle-liquid-biopsy-beats-the-gold-standard-when-it-comes-to-identifying-cells-that-are-indicative-of-cancer-spread-938952.html Wed, 20 Jan 2021 07:30:00 -0500 https://www.proactiveinvestors.com/companies/news/938952/angle-liquid-biopsy-beats-the-gold-standard-when-it-comes-to-identifying-cells-that-are-indicative-of-cancer-spread-938952.html ANGLE’s Parsortix liquid biopsy proving to be more than just a cancer detection device https://www.proactiveinvestors.com/companies/news/211923/angles-parsortix-liquid-biopsy-proving-to-be-more-than-just-a-cancer-detection-device-211923.html Mon, 14 Dec 2020 15:46:00 -0500 https://www.proactiveinvestors.com/companies/news/211923/angles-parsortix-liquid-biopsy-proving-to-be-more-than-just-a-cancer-detection-device-211923.html ANGLE says peer-reviewed journal published data demonstrates Parsortix system performance https://www.proactiveinvestors.com/companies/news/936055/angle-says-peer-reviewed-journal-published-data-demonstrates-parsortixsystem-performance-936055.html Wed, 09 Dec 2020 09:27:00 -0500 https://www.proactiveinvestors.com/companies/news/936055/angle-says-peer-reviewed-journal-published-data-demonstrates-parsortixsystem-performance-936055.html ANGLE looks to unlock commercial potential of liquid biopsy https://www.proactiveinvestors.com/companies/news/932670/angle-looks-to-unlock-commercial-potential-of-liquid-biopsy-932670.html Thu, 29 Oct 2020 07:44:00 -0400 https://www.proactiveinvestors.com/companies/news/932670/angle-looks-to-unlock-commercial-potential-of-liquid-biopsy-932670.html ANGLE raises around £20mln in new investment that will propel the business into the next phase of development https://www.proactiveinvestors.com/companies/news/932453/angle-raises-around-20mln-in-new-investment-that-will-propel-the-business-into-the-next-phase-of-development-932453.html Wed, 28 Oct 2020 07:05:00 -0400 https://www.proactiveinvestors.com/companies/news/932453/angle-raises-around-20mln-in-new-investment-that-will-propel-the-business-into-the-next-phase-of-development-932453.html ANGLE liquid biopsy moves into the crucial final phase of regulatory scrutiny as it seeks clearance from US Food & Drug Administration https://www.proactiveinvestors.com/companies/news/931855/angle-liquid-biopsy-moves-into-the-crucial-final-phase-of-regulatory-scrutiny-as-it-seeks-clearance-from-us-food--drug-administration-931855.html Tue, 20 Oct 2020 06:26:00 -0400 https://www.proactiveinvestors.com/companies/news/931855/angle-liquid-biopsy-moves-into-the-crucial-final-phase-of-regulatory-scrutiny-as-it-seeks-clearance-from-us-food--drug-administration-931855.html ANGLE completes FDA submission for Parsortix system for metastatic breast cancer https://www.proactiveinvestors.com/companies/news/930126/angle-completes-fda-submission-for-parsortix-system-for-metastatic-breast-cancer-930126.html Mon, 28 Sep 2020 12:40:00 -0400 https://www.proactiveinvestors.com/companies/news/930126/angle-completes-fda-submission-for-parsortix-system-for-metastatic-breast-cancer-930126.html ANGLE completes FDA submission process for ground-breaking liquid biopsy https://www.proactiveinvestors.com/companies/news/930074/angle-completes-fda-submission-process-for-ground-breaking-liquid-biopsy-930074.html Mon, 28 Sep 2020 06:32:00 -0400 https://www.proactiveinvestors.com/companies/news/930074/angle-completes-fda-submission-process-for-ground-breaking-liquid-biopsy-930074.html ANGLE helps crack the mystery of cancer spread https://www.proactiveinvestors.com/companies/news/929761/angle-helps-crack-the-mystery-of-cancer-spread-929761.html Wed, 23 Sep 2020 06:59:00 -0400 https://www.proactiveinvestors.com/companies/news/929761/angle-helps-crack-the-mystery-of-cancer-spread-929761.html ANGLE PLC: Proactive One2One Virtual Conference https://www.proactiveinvestors.com/companies/news/927848/angle-plc-proactive-one2one-virtual-conference-927848.html Sat, 29 Aug 2020 10:07:00 -0400 https://www.proactiveinvestors.com/companies/news/927848/angle-plc-proactive-one2one-virtual-conference-927848.html ANGLE highlights research showing potential for Parsortix to assess patient response to immunotherapy https://www.proactiveinvestors.com/companies/news/926678/angle-highlights-research-showing-potential-for-parsortix-to-assess-patient-response-to-immunotherapy-926678.html Fri, 14 Aug 2020 06:30:00 -0400 https://www.proactiveinvestors.com/companies/news/926678/angle-highlights-research-showing-potential-for-parsortix-to-assess-patient-response-to-immunotherapy-926678.html ANGLE notes USC study highlighting advantages of Parsortix over standard tissue biopsy https://www.proactiveinvestors.com/companies/news/924562/angle-notes-usc-study-highlighting-advantages-of-parsortix-over-standard-tissue-biopsy-924562.html Mon, 20 Jul 2020 07:20:00 -0400 https://www.proactiveinvestors.com/companies/news/924562/angle-notes-usc-study-highlighting-advantages-of-parsortix-over-standard-tissue-biopsy-924562.html ANGLE hails major progress, targets regulator submissions in third quarter of 2020 https://www.proactiveinvestors.com/companies/news/922727/angle-hails-major-progress-targets-regulator-submissions-in-third-quarter-of-2020-922727.html Thu, 25 Jun 2020 07:30:00 -0400 https://www.proactiveinvestors.com/companies/news/922727/angle-hails-major-progress-targets-regulator-submissions-in-third-quarter-of-2020-922727.html ANGLE PLC's Andrew Newland updates as blood donations restart to support its key studies https://www.proactiveinvestors.com/companies/news/922440/angle-plc-s-andrew-newland-updates-as-blood-donations-restart-to-support-its-key-studies-922440.html Mon, 22 Jun 2020 11:20:00 -0400 https://www.proactiveinvestors.com/companies/news/922440/angle-plc-s-andrew-newland-updates-as-blood-donations-restart-to-support-its-key-studies-922440.html ANGLE restarts work on FDA submission and ovarian cancer study recruitment https://www.proactiveinvestors.com/companies/news/922403/angle-restarts-work-on-fda-submission-and-ovarian-cancer-study-recruitment-922403.html Mon, 22 Jun 2020 06:33:00 -0400 https://www.proactiveinvestors.com/companies/news/922403/angle-restarts-work-on-fda-submission-and-ovarian-cancer-study-recruitment-922403.html ANGLE liquid biopsy shown to have potential in “new and promising area” of cancer treatment https://www.proactiveinvestors.com/companies/news/919338/angle-liquid-biopsy-shown-to-have-potential-in-new-and-promising-area-of-cancer-treatment-919338.html Tue, 12 May 2020 06:29:00 -0400 https://www.proactiveinvestors.com/companies/news/919338/angle-liquid-biopsy-shown-to-have-potential-in-new-and-promising-area-of-cancer-treatment-919338.html ANGLE says liquid biopsy system proves effective in helping scientists assess treatment options for men with advanced prostate cancer https://www.proactiveinvestors.com/companies/news/918703/angle-says-liquid-biopsy-system-proves-effective-in-helping-scientists-assess-treatment-options-for-men-with-advanced-prostate-cancer-918703.html Mon, 04 May 2020 06:43:00 -0400 https://www.proactiveinvestors.com/companies/news/918703/angle-says-liquid-biopsy-system-proves-effective-in-helping-scientists-assess-treatment-options-for-men-with-advanced-prostate-cancer-918703.html ANGLE CEO reports 'progress across multiple fronts' and talks big new opportunity in immunotherapy https://www.proactiveinvestors.com/companies/news/918317/angle-ceo-reports--progress-across-multiple-fronts--and-talks-big-new-opportunity-in-immunotherapy-918317.html Tue, 28 Apr 2020 13:05:00 -0400 https://www.proactiveinvestors.com/companies/news/918317/angle-ceo-reports--progress-across-multiple-fronts--and-talks-big-new-opportunity-in-immunotherapy-918317.html ANGLE identifies role for liquid biopsy in the development of the next generation of cancer immunotherapies https://www.proactiveinvestors.com/companies/news/918247/angle-identifies-role-for-liquid-biopsy-in-the-development-of-the-next-generation-of-cancer-immunotherapies-918247.html Tue, 28 Apr 2020 06:53:00 -0400 https://www.proactiveinvestors.com/companies/news/918247/angle-identifies-role-for-liquid-biopsy-in-the-development-of-the-next-generation-of-cancer-immunotherapies-918247.html Morning View - Speculation over gradual reopening helps the risk sentiment  https://www.proactiveinvestors.com/companies/news/917523/morning-view---speculation-over-gradual-reopening-helps-the-risk-sentiment-917523.html Fri, 17 Apr 2020 11:17:00 -0400 https://www.proactiveinvestors.com/companies/news/917523/morning-view---speculation-over-gradual-reopening-helps-the-risk-sentiment-917523.html ANGLE device yields positive results in Athens head and neck cancer study https://www.proactiveinvestors.com/companies/news/917474/angle-device-yields-positive-results-in-athens-head-and-neck-cancer-study-917474.html Fri, 17 Apr 2020 06:32:00 -0400 https://www.proactiveinvestors.com/companies/news/917474/angle-device-yields-positive-results-in-athens-head-and-neck-cancer-study-917474.html ANGLE says it is well funded and primed for action once coronavirus restrictions are lifted https://www.proactiveinvestors.com/companies/news/916200/angle-says-it-is-well-funded-and-primed-for-action-once-coronavirus-restrictions-are-lifted-916200.html Tue, 31 Mar 2020 07:32:00 -0400 https://www.proactiveinvestors.com/companies/news/916200/angle-says-it-is-well-funded-and-primed-for-action-once-coronavirus-restrictions-are-lifted-916200.html ANGLE device plays key role in assessing spread of lung cancer to the brain https://www.proactiveinvestors.com/companies/news/914148/angle-device-plays-key-role-in-assessing-spread-of-lung-cancer-to-the-brain-914148.html Tue, 03 Mar 2020 12:53:00 -0500 https://www.proactiveinvestors.com/companies/news/914148/angle-device-plays-key-role-in-assessing-spread-of-lung-cancer-to-the-brain-914148.html ANGLE says Italian study demonstrates key advantages of its Parsortix system in detecting renal cell carcinoma https://www.proactiveinvestors.com/companies/news/913830/angle-says-italian-study-demonstrates-key-advantages-of-its-parsortix-system-in-detecting-renal-cell-carcinoma-913830.html Thu, 27 Feb 2020 13:25:00 -0500 https://www.proactiveinvestors.com/companies/news/913830/angle-says-italian-study-demonstrates-key-advantages-of-its-parsortix-system-in-detecting-renal-cell-carcinoma-913830.html